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Lectins  are  carbohydrate  recognition  proteins.  cMoL,  a  coagulant  Moringa  oleifera Lectin,  was  isolated
from  seeds  of the plant.  Structural  studies  revealed  a heat-stable  and pH  resistant  protein  with  101
amino  acids,  11.67  theoretical  pI and  81%  similarity  with  a M. oleifera  ﬂocculent  protein.  Secondary
structure  content  was  estimated  as  46% -helix,  12%  -sheets,  17%  -turns  and 25%  unordered  structures
belonging  to the  /  tertiary  structure  class.  cMoL  signiﬁcantly  prolonged  the  time  required  for bloodeywords:
oagulant Moringa oleifera lectin
rimary sequence
ircular dichroism
nticoagulant lectin and Hemostatic
coagulation,  activated  partial  thromboplastin  (aPTT)  and  prothrombin  times  (PT),  but was  not  so  effective
in prolonging  aPTT  in  asialofetuin  presence.  cMoL  acted  as  an anticoagulant  protein  on  in vitro  blood
coagulation  parameters  and at least  on  aPTT,  the  lectin  interacted  through  the  carbohydrate  recognition
domain.
© 2013 Elsevier B.V. Open access under the Elsevier OA license.
arameters
. Introduction
Lectins are a group of proteins which recognize and bind mono-
nd oligosaccharides [1,2]. They can bind to carbohydrate moieties
n the surface of erythrocytes and agglutinate the cells, without
ltering the carbohydrate structure [3]. Lectins exist in viruses
nd all forms of life, however the best known are extracted from
lants, especially seeds, organ of stock, which is a major source
o obtain these molecules [4]. Hundreds of lectins have been puri-
ed and their sugar speciﬁcities identiﬁed, which has enabled their
evelopment into powerful tools for the puriﬁcation, separation,
nd structural analysis of glicoproteins [5], as well as recognition
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Open access under the Elsevier OA license.molecules inside cells, on cell surfaces, and in physiological ﬂuids
[6]. They have shown inhibitory activity against fungi and bacteria
[7,8], insects [9], viruses [10] and cytotoxic effects against tumor
cells lines [11].
Physical-chemistry characterization of lectins is important to
explain the function in different biological processes [12]. Struc-
tural biology of macromolecules searches products potentially
useful for solving biochemical problems and eventually develops
new therapeutical agents [13]. To study structures of macro-
molecule, spectroscopic techniques such as circular dichroism (CD)
is used, where optically active substances will absorb differently left
and right circularly polarized light, and the difference in absorption
of components is measured. The method has been extensively used
to unravel secondary structure of proteins giving information on
the effect of added ligands [14]. Proteins with high -helical con-
tent shows CD spectrum in the far UV region as two negative CD
bands around 208–210 nm and 222–228 nm as well as one positive
band near 190–195 nm [15].Moringa oleifera,  known as horseradish or drumstick tree, is
widely found throughout India, Asia, some parts of Africa and Amer-
ica, belonging to the Moringaceae family [16,17]. Its constituents
such as leaf, ﬂower, fruit and bark have been anecdotally used
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s herbal medicines in treatments for inﬂammation, paralysis and
ypertension [18]. The seeds contain edible oils and water solu-
le substances (coagulant proteins) that can be used in drinking
ater clariﬁcation [19–22] or for treatment of selected dyeing efﬂu-
nts [23]. Lectins with coagulant properties were puriﬁed from
. oleifera seeds. Santos et al. [24] puriﬁed and partially char-
cterized coagulant M.  oleifera lectin, cMoL, the ﬁrst lectin with
oagulant properties for contaminants in water. cMoL is a basic
rotein, active at pH range 4.0–9.0 and complex sugar speciﬁcity
hich recognized mainly the glycoproteins azocasein and asialofe-
uin. WSMoL, Water-Soluble M.  oleifera Lectin, was  detected by
antos et al. [25] as an acid glycoprotein, with higher hemagglu-
ination activity at pH 4.5, recognizing mainly fructose and porcine
hyroglobulin. Ferreira et al. [26] referred that this lectin has coag-
lant activity and is a natural coagulant for contaminants in water,
educing turbidity and bacterial proliferation. WSMoL  and cMoL
howed insecticidal activity against Aedes aegypti [27] and Anagasta
uehniella [28], respectively. Katre et al. [29] reported the presence
f a M.  oleifera lectin, MoL, a homodimer with molecular mass of
4 kDa and subunits (7.1 kDa) linked by disulﬁde bond(s). MoL  is
lso a glycoprotein with high stability and agglutinates human as
ell as rabbit erythrocytes.
cMoL is a protein with important biological activities [24,28],
owever its structural characterization was not completely elu-
idated. In this article, we report the primary structure, CD
haracterization and for the ﬁrst time the anticoagulant proper-
ies of a coagulant lectin from M.  oleifera on in vitro hemostatic
arameters of human blood coagulation.
. Materials and methods
.1. Isolation of coagulant M.  oleifera lectin (cMoL)
M.  oleifera seeds were collected on the campus of Universidade
ederal de Pernambuco, in Recife city, Northeast of Brazil. The
xtract, fraction and lectin were prepared according to Santos et al.
24], with modiﬁcations. Seeds were ground to ﬂour, which was
xtracted with 0.15 M NaCl at room temperature (25 ◦C) for 6 h,
nd a saline extract was obtained. Proteins were precipitated with
mmonium sulphate (60%) at room temperature for 4 h; the frac-
ion obtained after centrifugation (12,000 × g for 20 min  at 4 ◦C) was
ialyzed against water and 0.15 M NaCl. The fraction was applied
10 mg  of protein) on a guar gel column (10 cm × 1.0 cm)  previously
quilibrated (20 mL/h ﬂow rate) with 0.1 M NaCl. cMoL was  eluted
ith a saline gradient of 0.15, 0.3, 0.5 and 1 M NaCl. UV absorbance
as used to monitor samples. cMoL active fractions eluted with
.3 M NaCl were pooled, analyzed by HPLC and used in the exper-
ments. cMoL protein concentration was evaluated according to
owry et al. [30] using bovine serum albumin as standard at a range
f 0–500 g/mL and absorbance at 720 nm.
.2. Reversed-phase HPLC
cMoL was subjected to reverse-phase column C4 on HPLC sys-
em (Shimadzu) for purity analysis. The column was  equilibrated
ith solvent A [0.1% (v/v) triﬂuoroacetic acid (TFA) in H2O] and
luted using solvent B (90% acetonitrile in 0.1% TFA) in a linear gra-
ient, where B = 5% when t = 0 min, B = 5% at t = 5 min, B = 100% at
 = 60 min, B = 0% when t = 65 min. The elution proﬁle was  monitored
t 215 and 280 nm.
.3. Hemagglutination activity (HA)Glutaraldehyde-treated rabbit erythrocytes were obtained as
escribed by Bing, Weyand, and Stavinsky [31]. The lectin (50 L)
as serially two-fold diluted in microtiter V-plates containingogical Macromolecules 58 (2013) 31– 36
0.15 M NaCl before addition of 50 L 2.5% (v/v) suspension of
treated rabbit erythrocytes. The results were read after about
45 min  when the control, containing only erythrocytes fully pre-
cipitated, appeared as a dot at the bottom of the well. HA (inverse
of the titer) was  deﬁned as the highest sample dilution showing full
hemagglutination [4,32].
2.4. Primary sequence determination
Edman degradation [33] was performed with an automatic
gas-phase sequencer (492cLC; Applied Biosystems)  using condi-
tions recommended by the manufacturer. Samples (0.8 mg/mL)
for sequencing were reduced in 200 L of 0.25 M Tris–HCl buffer,
pH 8.5 containing 6 M guanidine–HCl, 1 mM EDTA and 5 mg  of
DTT, and alkylated with iodacetamide [34]. Then, the protein was
separated by reversed phase cromatography HPLC. The similar-
ity of sequences was searched using the BLAST protein sequence
database [35] and the sequences were aligned with the MULTALIN
program [36]. Theoretical pI was  calculated by ExPASy ProtParam
tool through the primary sequence of the protein.
2.5. Spectroscopic measurements
CD data were recorded on a Jasco J-810 spectropolarime-
ter. Samples were placed in a 0.5 mm  path length circu-
lar quartz cuvette. Lectin concentration was 0.2 mg/mL in
phosphate–borate–acetate (PBA) buffer for measurements in the
far UV region (250–190 nm), as an average of 8 scans. Data were
expressed in terms of mean residue ellipticity []. The secondary
structure estimative was calculated by deconvoluting the CD spec-
trum using the CDPro software package, which contains three
CD analysis programs, CONTINLL, SELCON3 and CDSSTR [37]. The
three programs were used with a reference protein set consist-
ing of 56 proteins, thus increasing the reliability of deconvolution.
Results were expressed as a mean of the three programs. CDPro
package also contains the Cluster program that was used to deter-
mine the tertiary structure class of cMoL [38]. To study the
pH effect on cMoL, the protein (0.2 mg/mL) was  incubated in
phosphate–borate–acetate buffer (PBA), 10 mM,  for 10 min, at pH
values of 2.0, 4.0, 6.0, 7.0, 8.0, 10 and 12. The temperature effect on
cMoL secondary structure was also analyzed. Protein samples were
heated at 40, 60, 80 and 100 ◦C for 30 min  and at 100 ◦C for 1 h. CD
measurements were recorded as described above.
2.6. Determination of activated partial thromboplastin time –
aPTT and prothrombin time – PT
aPTT and PT were determined in a semi-automated coagu-
lometer BFT II (Dade Behring). Total plasma was obtained by
centrifugation of human blood samples at 1726 × g, for 15 min
(25 ◦C). PT assay control was  made with 50 L of saline and 50 L
of plasma, incubation for 60 s, with subsequent addition of 100 L
of reagent (Thromborel S-Dade Behring). cMoL in different concen-
trations (3.0, 15, 30, 37.5, 45 and 60 g/mL) in 50 L was incubated
(60 s) with 50 L of plasma, followed by subsequent addition of
100 L of reagent. aPTT assay control was made with 50 L of
saline, 50 L of plasma and 50 L of aPTT reagent (Dade actin acti-
vated cephaloplastin reagent-Dade Behring), incubation for 120 s
and subsequent addition (50 L) of 0.025 M calcium chloride. cMoL
(3.0, 15, 30, 37.5, 45 and 60 g/mL) was  incubated for 120 s with
50 L of plasma and 50 L of the aPTT reagent, followed by addition
of 50 L of 0.025 M calcium chloride. The blood coagulation assays
were also performed with cMoL (50 L) inhibited by glycoprotein.
cMoL was  previously incubated with asialofetuin (0.5 mg/mL) for
15 min  e then the assay proceeded as described above. Each assay
was made in duplicate and results were expressed as average of
of Biological Macromolecules 58 (2013) 31– 36 33
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Fig. 1. cMoL proﬁle by reverse phase chromatography using VYDAC C4 column in
a  HPLC system. Fractions eluted with 0.3 M NaCl on an afﬁnity guar gel column
were assessed for homogeneity evaluation. Absorbance was performed at 280 nm.
The protein fraction was eluted using a linear gradient: solvent B (90% acetonitrile
F
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 independent protocols (±s.e.m). All experiments were approved
y the Ethics Committee of the Universidade Federal de São Paulo,
umber CEP 1793/11, according to Brazilian federal law.
.7. Statistical analysis
Differences between means values were analyzed using one-
ay ANOVA followed by Tukey’s multi-comparison test in the
oagulation assays. A p value < 0.05 was considered signiﬁcant.
. Results and discussion
.1. Structural analysis of cMoL
cMoL is a coagulant M.  oleifera lectin, puriﬁed by Santos et al.
24] after saline extraction and guar gel column chromatogra-
hy. The coagulant property of this lectin is related to reduction
f contaminants in water; cMoL promoted turbidity reduction
f approximately 92% (in relation to negative control) similar to
he positive control aluminum sulphate on water with high and
ow turbidity of kaolin clay [24]. By hemagglutination assays, the
rotein is resistant to change in pH, thermostable, agglutinates
rythrocytes from rabbit and human blood types [24] and have
nsecticidal activity [28]. By a new and simple protocol, Santos et al.
24] puriﬁed and partly characterized a lectin different from those
lready reported, WSMoL  [25] and MoL  [29]. The knowledge of
he structure and physicochemical properties of cMoL is needed
o understand the mechanisms of action involved in the biologi-
al activities developed by the lectin and thus integrate the study
f structure-function of the protein. Reverse phase chromatogra-
hy was made to assess the purity of the fractions obtained in guar
el column. Fig. 1 shows the cMoL proﬁle obtained by HPLC. The
eak represents cMoL fractions from guar gel columm eluted with
.3 M NaCl. The detection of a single peak shows homogeneity in the
uriﬁcation, so this step puriﬁed efﬁciently the lectin, biologically
ctive.
Highly pure fractions of proteins are important for the perfor-
ance of amino acid sequence and circular dichroism analysis. In
his study, the complete sequence of cMoL was obtained and com-
ared with other protein sequences of the NCBI-BLAST data bank;
he search indicated similarity with the sequence of M.O2.1, a ﬂoc-
ulent active protein from M.  oleifera [19]. These sequences were
ligned using MULTALIN program (Fig. 2). The sequence revealed
hat cMoL is a protein with 101 amino acids, two  chains, and has
1% of similarity with M.O2.1, which presents 6.5 kDa and isoelectric
oint above pH 10 [19]. It is important to note that cMoL have eight
ysteine residues, which may  be involved in the disulﬁde bonds.
ig. 2. Analysis of cMoL sequence and multiple sequence alignment of cMoL with ﬂocculen
n  gray background. The cysteine residues of both proteins are indicated in black backgroin  0.1% TFA), where B = 5% when t = 0 min, B = 5% at t = 5 min, B = 100% at t = 60 min,
B  = 0% when t = 65 min.
cMoL is a basic protein with a theoretical pI of 11.67 indicating a
strong positive charge on the surface and conﬁrming its cationic
nature. High contents of glutamine (26.7%), alanine (6.9%), proline
(6.9%) and 17 positively charged amino acids (16 arginines and 2
histidines) are also present in the lectin structure. Several protein
families with ﬂocculent/coagulant activity are present in M.  oleifera
seeds [19,39]. cMoL must develop its coagulant activity in water
due to interactions among charges, as proposed to MO2.1 [19,20]
and not through binding to carbohydrate recognition site. Further
studies on the genome and proteome of M.  oleifera seeds could con-
tribute to unravel the function of products from a unique gene(s)
in the plant [24].
The native cMoL molecular weight obtained by Santos et al. [24]
through Sephacryl S-300 size exclusion chromatography revealed
a single peak corresponding to an apparent molecular mass of
30,000 Da; however, the molecular weight estimated to cMoL
through the primary sequence revealed that the protein showed
11,928 Da. These results suggested that cMoL is a trimer consisting
of three subunits of 11,928 Da. cMoL is not a glycosylated protein,
which was  conﬁrmed through Schiff’s reagent staining by Santos
et al. [24].
Analyses of CD spectrum shows a typical shape and features of a
mainly -helical secondary structure, i.e.,  two  negative bands at 222
and 209 nm,  and a positive band at 192 nm (Fig. 3). The secondary
structure content of cMoL was estimated at 46% -helix, 12% -
sheets, 17% -turns and 25% unordered structures with root mean
t M. oleifera protein MO2.1 (2111235A). Identical residues among them are displayed
und.
34 L.d.A. Luz et al. / International Journal of Biological Macromolecules 58 (2013) 31– 36
Fig. 3. CD spectrum of cMoL in 10 mM PBA, pH 7.0. Measurements were recorded
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Table 1
cMoL secondary structure estimated from CD spectra at different pH values.
pH -Helix (%) -Sheet (%) -Turn (%) Unordered (%)
2.0 43 13 18 26
7.0 46 12 17 25
12.0  39 15 19 27
Quantitative predictions were performed using CDPro software.
Table 2
cMoL secondary structure estimated from CD spectra at different temperatures.
Temperatures -Helix (%) -Sheet (%) -Turn (%) Unordered (%)
40 ◦C 51 9 16 25
60 ◦C 51 8 16 25
80 ◦C 42 10 21 27
100 ◦C (30 min) 18 25 23 33
F
3s  an average of 8 scans for protein solutions of 0.2 mg/mL, at 25 ◦C. CD spectrum
econvolution indicated 46% -helix, 12% -sheet, 17% -turn, 25% unordered struc-
ure.
quare deviation (RMS) lower than 2% for all structures. The Clus-
er analysis showed that cMoL belongs to the / tertiary structure
lass, corroborated by results of secondary structure estimative.
or / proteins, the 222 nm band generally has a higher intensity
han 208–210 nm band, whereas for the + proteins the reverse
s observed [38]. The content of -helices estimated for cMoL was
imilar to that determined for MO,  the coagulant protein puriﬁed
y Ndabigengesere and Narasiah [40]. Kwaambwa and Maikokera
41] reported that this protein presents secondary structural com-
onents of 58% -helix, 10% -sheet and 33% unordered structures,
ith RMS  lower than 4% for all structures. But different from MoL,
n alpha–beta lectin, isolated by Katre et al. [29] which containing
8% -helix, 23% -sheet, 20% turn and 28% of unordered struc-
ure. The secondary structure content of cMoL and MoL  revealed
hat these lectins have different content of secondary structures
ut consist of a mixture of alpha and beta structures.
Generally, the functional stability is accompanied by structural
tability. Fig. 4a shows CD spectra of cMoL in pH values of 2.0, 7.0
nd 12. The secondary structure of the protein did not change in
cidic and alkaline conditions as shown in the CD spectra, corrobo-
ating with the data on the stability of biological activity in function
f pH. The content of each secondary structure of cMoL at differ-
nt pH range is shown in Table 1. No signiﬁcant change due to
H was observed in the estimated secondary structures from CD
pectra. Sample spectra from other pH values were omitted since
ig. 4. (a) CD spectra of cMoL (0.2 mg/mL), in 10 mM PBA buffer, at pH 2.0 (), 7.0 () an
0  min  (). The spectra after heating at 100 ◦C for 1 h is also represented ().100 ◦C (1 h) 7 26 27 40
Quantitative predictions were performed using CDPro software.
small changes were detected. cMoL and MoL  have as a common fea-
ture activity in acidic and alkaline conditions [24,29]. Other lectin
with similar pH stability is a chitin-binding lectin from rhizomes
of Setcreasea purpurea (SPL). SPL is a homotetrameric protein with
hemagglutinating activity stable in pH range of 2.0–9.0 [42].
Treating cMoL at 100 ◦C and subsequent evaluation by HA
revealed the lectin as a thermostable protein [24], however by accu-
rate CD analysis, the protein conformation is maintained only until
80 ◦C for 30 min  (Fig. 4b). When cMoL was  subjected to heating at
80 ◦C, change in -helix content was  veriﬁed, followed by a gentle
increase of -structures while unordered structures did not alter.
The estimated unordered structure content increased when cMoL
was heated at 100 ◦C for 30 min  and 1 h (Table 2). High temperature
is a powerful denaturing agent leading to protein unfolding through
breaking of hydrogen bonds that maintain protein structure [43].
Thermostability is a common feature of proteins from M.  oleifera
seeds. MOCP, a coagulant protein isolated by Ghebremichael et al.
[21] remained active after 5 h heat treatment at 95 ◦C. Katre et al.
[29] also reported that MoL  is a heat-stable protein, which retains
the activity even after incubating at 85 ◦C up to 30 min  at pH 7.2.
3.2. cMoL effect on hemostatic parameters
The inﬂuence of cMoL on blood coagulation was  determined
by activated partial thromboplastin time (aPTT) and prothrombin
time (PT) (Fig. 5). The positive control used in the assays was  plasma
of healthy volunteer donors with normal values for clotting times.
A variety of new anticoagulants are being developed and tested
d 12 () and (b) cMoL spectra after heating at 40 (), 60 (), 80 () and 100 ◦C for
L.d.A. Luz et al. / International Journal of Biological Macromolecules 58 (2013) 31– 36 35
Fig. 5. In vitro effect of cMoL in hemostatic parameters. Activated partial thrombo-
plastin time (aPTT, a) and prothrombin time (PT, b) were determined. The statistical
signiﬁcance was  evaluated using one-way ANOVA, followed by Tukey’s test. A
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Fig. 6. Blood coagulation assays in the presence of cMoL inhibited by asialofetuin
(0.5 mg/mL). Lectin was previously incubated (15 min) with asialofetuin. (a) Acti-
vated partial thromboplastin time (aPTT); (b) prothrombin time (PT). The statistical
signiﬁcance was evaluated using one-way ANOVA, followed by Tukey’s test. A p-
value < 0.05 was considered to indicate signiﬁcance. p < 0.05 (*) and p < 0.001 (**)
represent comparative analysis between cMoL inhibited by asialofetuin and con-
MLVO, LCBBC. Performed the experiments: LAL, MCCS, RSF, LAS,-value < 0.05 was considered to indicate signiﬁcance. p-Value < 0.05 (*) and p-
alue < 0.001 (**). R: ratio of sample coagulation time with control coagulation time.
ata represent means ± s.e.m., n = 3.
o inhibit the various steps in the coagulation cascade [44]. The
etermination of aPTT is particularly useful in monitoring the effect
f heparin and determining deﬁciencies of factors VIII, IX, XI and XII.
P reﬂects the activity of factor II (prothrombin), V, VII and X, whose
eﬁciency is accompanied by a prolongation of time required for
lot formation [45].
cMoL signiﬁcantly prolonged aPTT (to more than 300 s) and PT
Fig. 5b) coagulation time, at the assayed concentrations (3.0, 15, 30,
7.5, 45 and 60 g/mL) but the most affected parameter was  aPTT
Fig. 5a). Prolongation of aPTT suggests inhibition of the intrinsic
athway and/or common blood coagulation, while prolongation of
T suggests inhibition of the extrinsic pathway [46]. The intrinsic
nd extrinsic pathways converge in the formation of factor Xa [47].
ther lectins also signiﬁcantly prolongs both coagulation times.
ratylia mollis seed lectin (Cramoll 1,4), a mannose/glucose bind-
ng lectin, promotes almost two-fold increase of coagulation times
48]. Bauhinia forﬁcata lectin, BfL, increased only aPTT coagulation
ime but this effect was  not related to human plasma kallikrein or
uman factor Xa inhibition [49]. Thus cMoL showed an anticoagu-
ant activity, since in determining the R, the ratio between sample
oagulation time and control coagulation time [50] was  higher than
.0.
Signiﬁcant correlation between recognition and binding of
ectins to carbohydrates or glycoconjugates on cell surface or free
n biological ﬂuids are involved in many lectin effects, such as activ-
ty against insects, viruses, bacteria and cytotoxicity [27,42,51,52].
hen, to investigate cMoL interaction with coagulation factors,
lood coagulation assays were performed in the presence of
sialofetuin. This glycoprotein blocks the site of carbohydrate
ecognition of the lectin. aPTT assays showed a reduction in thetrols. Statistical signiﬁcance of cMoL in the presence and absence of glycoprotein
was also showed. R: ratio of sample coagulation time with control coagulation time.
Data represent means ± s.e.m., n = 3.
time required for blood coagulation in the presence of the inhibited
lectin by glycoprotein in the same assayed concentrations (Fig. 6a),
while PT was  not affected (Fig. 6b). These results suggest that cMoL
interacts with the carbohydrate portion of serine proteases of the
coagulation cascade from intrinsic pathway. No decrease in PT in
the presence of inhibited lectin suggests that the lectin should act
on the factors of the extrinsic pathway and/or under the factor Xa
by a different domain from the carbohydrate recognition.
4. Conclusions
In this article structural characteristics of cMoL were described;
also, for the ﬁrst time, the anticoagulant activity was  detected on
human blood coagulation process by a coagulant M.  oleifera seed
lectin. Structural analysis revealed cMoL common features with
another coagulant protein from M. oleifera. cMoL interactions in
blood coagulation must occur at least partially, by the carbohydrate
recognition domain. cMoL is the only currently described protein
from M. oleifera seeds that exhibits anticoagulant activity.
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